Over the last 7 days, the Life Sciences industry has dropped 9.6%, driven by a pullback from WuXi Biologics (Cayman) of 17%. On the other hand Genscript Biotech is actually up 7.9%. The industry has fallen 59% in the last year. Earnings are forecast to grow by 42% annually.
Has the Hong Kong Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 19 Mar 2024 | HK$120.3b | HK$33.3b | HK$3.7b | 47.6x | 32.7x | 3.6x |
Thu, 15 Feb 2024 | HK$115.1b | HK$32.3b | HK$3.0b | 43.6x | 38.6x | 3.6x |
Sat, 13 Jan 2024 | HK$206.0b | HK$32.4b | HK$3.0b | 85.9x | 68.9x | 6.4x |
Mon, 11 Dec 2023 | HK$208.4b | HK$32.3b | HK$3.0b | 81.4x | 69.7x | 6.4x |
Wed, 08 Nov 2023 | HK$268.7b | HK$30.2b | HK$2.7b | 46.9x | 100.2x | 8.9x |
Fri, 06 Oct 2023 | HK$245.6b | HK$30.2b | HK$2.7b | 41x | 91.8x | 8.1x |
Sun, 03 Sep 2023 | HK$235.0b | HK$30.3b | HK$2.7b | 41.8x | 86.9x | 7.7x |
Tue, 01 Aug 2023 | HK$239.4b | HK$28.5b | HK$2.7b | 23.4x | 87.1x | 8.4x |
Thu, 29 Jun 2023 | HK$209.3b | HK$28.4b | HK$2.7b | 20.9x | 77.4x | 7.4x |
Sat, 27 May 2023 | HK$229.1b | HK$28.9b | HK$2.8b | 22.6x | 81.5x | 7.9x |
Mon, 24 Apr 2023 | HK$265.7b | HK$29.5b | HK$2.9b | 25.1x | 90.5x | 9x |
Wed, 22 Mar 2023 | HK$258.2b | HK$26.4b | HK$2.1b | 23.7x | 124.6x | 9.8x |
Fri, 17 Feb 2023 | HK$301.0b | HK$26.5b | HK$2.1b | 25.2x | 144.7x | 11.4x |
Sun, 15 Jan 2023 | HK$378.5b | HK$26.8b | HK$2.2b | 27.5x | 173.4x | 14.1x |
Tue, 13 Dec 2022 | HK$278.2b | HK$25.9b | HK$2.0b | 29.1x | 140.5x | 10.8x |
Thu, 10 Nov 2022 | HK$237.3b | HK$25.4b | HK$1.8b | 22.3x | 130.3x | 9.3x |
Sat, 08 Oct 2022 | HK$247.8b | HK$25.7b | HK$1.9b | 20.2x | 130x | 9.6x |
Mon, 05 Sep 2022 | HK$343.4b | HK$26.3b | HK$2.1b | 27.3x | 167.1x | 13x |
Wed, 03 Aug 2022 | HK$372.4b | HK$22.3b | HK$2.0b | 11.7x | 183.1x | 16.7x |
Fri, 01 Jul 2022 | HK$376.3b | HK$22.4b | HK$2.1b | 15.4x | 180.9x | 16.8x |
Sun, 29 May 2022 | HK$284.4b | HK$22.4b | HK$2.1b | 13x | 136.6x | 12.7x |
Tue, 26 Apr 2022 | HK$280.0b | HK$22.9b | HK$2.2b | 13.3x | 125.6x | 12.2x |
Thu, 24 Mar 2022 | HK$347.6b | HK$21.9b | HK$2.3b | 21.7x | 154.4x | 15.9x |
Sat, 19 Feb 2022 | HK$341.4b | HK$18.7b | HK$2.8b | 23.2x | 121.1x | 18.2x |
Mon, 17 Jan 2022 | HK$477.6b | HK$18.7b | HK$2.8b | 29.6x | 170.2x | 25.6x |
Wed, 15 Dec 2021 | HK$524.6b | HK$18.7b | HK$2.8b | 35.6x | 187x | 28.1x |
Fri, 12 Nov 2021 | HK$542.4b | HK$18.6b | HK$2.8b | 34.9x | 194.1x | 29.2x |
Sun, 10 Oct 2021 | HK$572.2b | HK$18.5b | HK$2.8b | 51.7x | 207.5x | 31x |
Tue, 07 Sep 2021 | HK$625.4b | HK$18.4b | HK$2.7b | 49.7x | 228x | 34x |
Thu, 05 Aug 2021 | HK$669.9b | HK$18.4b | HK$2.7b | 56.1x | 244.2x | 36.4x |
Sun, 09 May 2021 | HK$524.9b | HK$15.7b | HK$1.4b | 47.5x | 363.3x | 33.5x |
320.2x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 1.55% | |
Healthcare | 4.12% | |
Life Sciences | -9.62% | |
Clinical Research and Equipment | -9.62% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1548 Genscript Biotech | HK$16.74 | 7.9% +HK$2.6b | -9.0% | PS5.4x | |
1873 Viva Biotech Holdings | HK$0.54 | 3.8% +HK$42.8m | -64.5% | PS0.4x |